large B cell lymphoma

IPO Update: Cargo Therapeutics Readies Plans For $300 Million IPO
Seeking Alpha
Mon, 11/6/23 - 07:21 pm
Cargo Therapeutics
IPOs
large B cell lymphoma
Allogene Therapeutics Initiates Industry’s First Allogeneic CAR T Phase 2 Trial
Global Newswire
Thu, 10/6/22 - 07:06 pm
Allogene
large B cell lymphoma
clinical trials
ALLO-501a
CAR-T